drugset / Trial / NCT03198000

A Study to Evaluate the Efficacy of Investigational OTC Eye Drops

NCT03198000

Phase 3 Completed 120 enrolled Johnson & Johnson Consumer Inc. (J&JCI)
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a single center, double-blinded study designed to demonstrate the therapeutic equivalence of over-the-counter eye drops in healthy adults with red eyes.

Timeline

Start
2017-06-28
Primary completion
2017-07-21
Completion
2017-07-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Tetrahydrozoline Small molecule 0.05 % Other

Indications

No indication recorded.